West Virginia Healthcare
Compliance Guide

West Virginia presents a dynamic, though often conservative, regulatory landscape for healthcare companies. The state has generally embraced telehealth as a means to expand access to care, particularly in its rural areas, but maintains stringent controls over prescribing practices and corporate structures. Recent legislative actions have aimed to clarify telehealth regulations and enhance interstate licensure opportunities, reflecting a proactive approach to modern healthcare delivery while upholding patient safety standards. The West Virginia Board of Medicine (WVBOM), West Virginia Board of Osteopathic Medicine (WVBOM), and West Virginia Board of Pharmacy (WVBOP) are the primary regulatory bodies governing professional licensure and practice. The general business climate for healthcare operations is cautiously welcoming, with an emphasis on compliance with established professional practice doctrines. Companies looking to expand into West Virginia must navigate a regulatory environment that balances innovation with traditional healthcare oversight, particularly concerning the Corporate Practice of Medicine and controlled substance prescribing. For instance, the state has actively participated in interstate compacts to streamline provider licensure, indicating a willingness to adapt to a nationalized healthcare provider landscape, yet it maintains robust state-specific requirements for patient-provider relationships and practice standards. Understanding these nuances is critical for successful and compliant operations.

West Virginia maintains a robust Corporate Practice of Medicine (CPOM) doctrine, primarily rooted in statutory law and reinforced by regulatory interpretation, which prohibits or severely restricts corporations, other than professional corporations, from employing physicians or owning medical practices. The legal basis for CPOM in West Virginia is not explicitly codified as a single statute but is derived from various provisions within the West Virginia Code governing professional licensure and corporate structures. Key provisions include W. Va. Code §30-3-1 et seq. (Medical Practice Act) and W. Va. Code §30-14-1 et seq. (Osteopathic Physicians and Surgeons), which define the practice of medicine as requiring a license and generally restrict who can engage in such practice. Furthermore, W. Va. Code §31D-2-201 and §31D-2-202 govern professional corporations, implicitly reinforcing that only licensed professionals or professional entities can provide professional services. This framework means that non-physicians or general business corporations cannot directly employ physicians or other licensed healthcare practitioners to provide medical services, nor can they own entities that do. The primary rationale is to prevent the commercialization of medicine, maintain the physician's independent professional judgment, and protect the patient-physician relationship from undue corporate influence. For telehealth companies, medspas, dental practices, and wellness clinics, this has significant implications. To comply, these entities must typically adopt a 'friendly physician' or Professional Corporation (PC)-Management Services Organization (MSO) model. Under this structure, the clinical entity (PC) is owned by a licensed physician (or other appropriate licensed professional for dental or chiropractic services) and employs the licensed practitioners. The MSO, a separate management company, provides administrative, non-clinical services (e.g., billing, marketing, IT, facilities) to the PC under a Management Services Agreement (MSA). The MSA must be carefully structured to ensure the MSO does not exert control over clinical decision-making, engage in fee-splitting, or otherwise violate CPOM. Non-physicians can own the MSO, but not the PC. Dental practices, chiropractic clinics, and medspas (which often involve medical procedures) are similarly affected; the professional component must be owned and controlled by licensed professionals. For instance, a medspa offering medical procedures like injectables or laser treatments must ensure the medical director or an owning physician maintains clinical oversight and ownership of the professional entity. The WVBOM and WVBOP rigorously enforce these distinctions, scrutinizing arrangements that appear to circumvent the CPOM doctrine. Any structure that allows a lay entity to profit directly from the provision of professional medical services or to control clinical decisions will likely face regulatory challenge. Therefore, a compliant business structure is paramount for operations in West Virginia.

West Virginia has established a clear framework for telehealth, generally embracing its use to expand access to care. The West Virginia Board of Medicine (WVBOM) and West Virginia Board of Osteopathic Medicine (WVBOM) regulations, primarily found in W. Va. Code R. §11-1A-1 et seq. (Board of Medicine) and W. Va. Code R. §24-1A-1 et seq. (Board of Osteopathic Medicine), define telehealth and set forth requirements. A provider-patient relationship can be established via telehealth, provided it meets the standard of care that would apply to an in-person encounter. This typically requires a real-time, interactive audio-visual encounter to establish a new relationship, although follow-up care may utilize other modalities. Permitted modalities include: synchronous audio-visual communication (real-time video conferencing), which is generally preferred for initial patient encounters; synchronous audio-only communication (real-time telephone calls) may be permitted in certain circumstances, particularly for follow-up care or when video is not available, but its use for establishing a new relationship or prescribing controlled substances is restricted; and asynchronous (store-and-forward) technology for transmitting medical information, which is permissible when appropriate for the clinical service, but typically not sufficient for establishing a new patient relationship or for initial diagnosis and treatment of complex conditions. There are no specific telehealth registration requirements for providers beyond their standard professional licensure with the respective West Virginia licensing board. However, providers must be fully licensed in West Virginia to provide telehealth services to patients located in the state. Informed consent is a critical requirement. Prior to providing telehealth services, providers must obtain informed consent from the patient, which includes informing the patient about the nature of telehealth, its potential benefits and risks, and the patient's rights, including the right to withdraw consent. This consent should be documented in the patient's medical record. There are generally no geographic restrictions within West Virginia for telehealth services, meaning a licensed provider can treat a patient anywhere within the state. However, providers must ensure their telehealth platform complies with HIPAA and other privacy regulations. The state's focus is on ensuring the quality and safety of care delivered via telehealth, requiring that it be equivalent to in-person care. This includes appropriate documentation, maintenance of medical records, and adherence to professional standards of practice.

West Virginia maintains strict regulations for prescribing controlled substances via telehealth, largely aligning with federal DEA requirements while adding state-specific nuances. The ability to prescribe controlled substances via telehealth is primarily governed by W. Va. Code R. §11-1A-12 (Board of Medicine) and W. Va. Code R. §24-1A-12 (Board of Osteopathic Medicine), which specifically address telehealth prescribing. For Schedule II controlled substances, an in-person examination is generally required before an initial prescription can be issued. Exceptions may apply in public health emergencies or under specific DEA waivers. For Schedule III-V controlled substances, an initial prescription may be issued via telehealth if a legitimate patient-provider relationship has been established through a real-time, interactive audio-visual examination sufficient to meet the standard of care. Audio-only encounters are generally insufficient for initial controlled substance prescribing. All prescriptions, whether for controlled or non-controlled substances, must be issued for a legitimate medical purpose in the usual course of professional practice. DEA registration is mandatory for any provider prescribing controlled substances, and the provider's DEA registration must be tied to a West Virginia practice address if they are prescribing to patients in the state. West Virginia mandates the use of the state's Prescription Drug Monitoring Program (PDMP), known as the West Virginia Controlled Substances Monitoring Program (CSMP), for all prescribers of Schedule II, III, IV, and V controlled substances. W. Va. Code §60A-9-1 et seq. requires prescribers to check the CSMP database before prescribing an opioid or benzodiazepine and periodically thereafter. Failure to do so can result in disciplinary action. There are no explicit quantity or refill limitations specific to telehealth prescribing beyond those that apply to in-person prescribing, which are often dictated by the specific drug and clinical guidelines. However, providers are expected to exercise professional judgment and adhere to best practices for safe prescribing, including tapering protocols and risk assessments. Special rules apply to specific drug classes. For example, GLP-1s (e.g., for weight loss) and testosterone (hormone therapy) are not controlled substances but require careful assessment and monitoring. Prescribing these via telehealth must meet the same standard of care as in-person care, including appropriate diagnostic workups and follow-up. For stimulants (e.g., for ADHD), which are Schedule II, the general rule of an initial in-person examination applies unless a specific exception is met. The WVBOP also plays a crucial role in regulating pharmacies and dispensing. Providers must ensure their prescriptions are clear, complete, and legally valid to be filled by West Virginia pharmacies.

West Virginia's scope of practice regulations for mid-level providers, including Nurse Practitioners (NPs) and Physician Assistants (PAs), are defined by their respective licensing boards and state statutes, reflecting a trend towards expanded roles while maintaining physician oversight in many areas. Nurse Practitioners (NPs) in West Virginia operate under a 'reduced practice' model, rather than full practice authority. While NPs can diagnose, treat, and prescribe medications (including controlled substances), they are generally required to practice in collaboration with a physician. W. Va. Code §30-7-15a and W. Va. Code R. §19-4-1 et seq. (Board of Examiners for Registered Professional Nurses) outline the requirements for advanced practice registered nurses (APRNs), including NPs. A collaborative practice agreement (CPA) with a physician is typically required, which outlines the scope of the NP's practice, consultation protocols, and referral mechanisms. While the CPA does not require direct supervision for every patient encounter, it mandates a formal relationship and oversight framework. The specific requirements for the CPA, including review and approval by the Board of Nursing, are detailed in the regulations. Physician Assistants (PAs) in West Virginia also practice under a physician supervision model. W. Va. Code §30-3-16 and W. Va. Code R. §11-1B-1 et seq. (Board of Medicine) govern PA practice. PAs must practice under the supervision of a licensed physician, and their scope of practice is determined by the supervising physician's scope of practice and the PA's education, training, and experience, as outlined in a supervision agreement or protocol. The supervising physician is responsible for the PA's actions and must be readily available for consultation. While PAs can perform many medical tasks, including prescribing, their autonomy is directly linked to their supervising physician. For Medical Assistants (MAs) in medspas or other clinical settings, their scope of practice is highly restricted and generally limited to administrative tasks or delegated clinical tasks that do not require independent medical judgment. W. Va. Code §30-3-1 et seq. and W. Va. Code R. §11-1A-1 et seq. define who can perform medical acts. MAs cannot perform procedures that require a license, such as injections (e.g., Botox, fillers), laser treatments, or IV therapy. These procedures must be performed by a licensed physician, NP, PA, or a properly delegated Registered Nurse (RN) under appropriate supervision. Delegation rules are strict; a licensed practitioner may delegate certain tasks to qualified personnel, but the delegating practitioner retains full responsibility for the delegated task. Therefore, medspas and similar clinics must ensure that all procedures are performed by appropriately licensed and supervised professionals, with MAs strictly adhering to their non-clinical or limited delegated roles.

Navigating business structures in West Virginia, particularly for healthcare entities, requires careful consideration of the Corporate Practice of Medicine (CPOM) doctrine and fee-splitting prohibitions. The Professional Corporation (PC)-Management Services Organization (MSO) model is the predominant compliant structure for healthcare businesses where non-physician ownership or investment is involved. A PC is a distinct legal entity (e.g., a Professional Limited Liability Company, PLLC, or Professional Corporation, PC) owned exclusively by licensed professionals (e.g., physicians for medical practices, dentists for dental practices) who provide the clinical services. This PC employs the licensed practitioners and is responsible for all clinical decisions and patient care. The MSO is a separate, non-professional entity that can be owned by non-physicians or investors. The MSO provides all non-clinical, administrative, and management services to the PC under a Management Services Agreement (MSA). These services typically include billing, scheduling, marketing, IT, human resources, facilities management, and equipment leasing. The MSA must be carefully drafted to ensure the MSO's compensation is a fair market value for the services rendered and is not tied to a percentage of clinical revenue, as this could be construed as illegal fee-splitting. Fee-splitting is generally prohibited under W. Va. Code §30-3-14 (Medical Practice Act) and similar provisions for other professions, which forbid licensed professionals from sharing fees with unlicensed individuals or entities for patient referrals or professional services. The MSO's compensation must be structured as a fixed fee, a cost-plus arrangement, or a percentage of gross collections that is clearly for management services and not for the referral of patients or the provision of medical services. Professional Corporation requirements in West Virginia are outlined in W. Va. Code §31D-2-201 et seq. These statutes require that professional corporations be organized for the sole purpose of rendering a specific professional service, and all shareholders, directors, and officers must be licensed in the profession for which the corporation is organized. This reinforces the CPOM doctrine. For telehealth companies, medspas, and wellness clinics, the PC-MSO model allows for external investment and efficient management while preserving the professional autonomy of the licensed practitioners. The MSO handles the business aspects, allowing the PC to focus solely on patient care. It is crucial that the MSA clearly delineates responsibilities, ensures the PC retains ultimate control over clinical decisions, and that the MSO's compensation is compliant with anti-kickback and fee-splitting laws. Failure to adhere to these structuring principles can lead to severe penalties, including license revocation, fines, and civil or criminal charges. Therefore, legal counsel experienced in West Virginia healthcare law is essential for proper business formation and ongoing compliance.

West Virginia has seen several significant regulatory developments and legislative efforts in 2024-2026 impacting telehealth, CPOM, and prescribing. One key area of focus has been the continued expansion and clarification of telehealth regulations. While specific new bills for 2025-2026 are still emerging, the trend from 2024 legislative sessions indicates a move towards solidifying temporary COVID-19 telehealth flexibilities into permanent law. For instance, discussions around W. Va. Code §30-3-13a (Telehealth Practice) and related regulations have focused on ensuring equitable reimbursement for telehealth services and clarifying the circumstances under which audio-only telehealth is permissible for establishing new patient relationships or prescribing, particularly for non-controlled substances. There's also been a continued push for interstate licensure compact participation. West Virginia is a member of the Interstate Medical Licensure Compact (IMLC), allowing eligible physicians to obtain licenses in multiple member states more efficiently. Similarly, the state is part of the Nurse Licensure Compact (NLC), facilitating multi-state practice for registered nurses and licensed practical nurses. Efforts are ongoing to join other compacts, such as the Psychology Interjurisdictional Compact (PSYPACT) and the Audiology and Speech-Language Pathology Interstate Compact (ASLPIC), to further streamline cross-state practice. Regarding CPOM, there haven't been major legislative overhauls, indicating the state's continued commitment to its existing framework. However, the West Virginia Board of Medicine and Board of Osteopathic Medicine remain vigilant in reviewing business arrangements, particularly those involving private equity or non-physician management, to ensure compliance with CPOM and anti-fee-splitting provisions. Enforcement cases typically involve unlicensed practice or arrangements deemed to compromise physician autonomy. Prescribing rules, especially for controlled substances, continue to be a high-priority area. While the federal Ryan Haight Act's in-person exam requirement for controlled substances remains a baseline, West Virginia's specific regulations for telehealth prescribing of controlled substances are subject to ongoing review, particularly concerning the use of telehealth for opioid use disorder treatment and mental health conditions. Any changes would likely focus on balancing access to care with robust safeguards against diversion and misuse. Companies should monitor the legislative sessions for House and Senate Bills related to healthcare, particularly those introduced by the Health and Human Resources committees, and regularly check for updates from the WVBOM, WVBOP, and WVBOP.

For healthcare companies entering West Virginia, a structured approach to compliance is essential. Here's actionable guidance: 1. Entity Formation & CPOM Compliance: Before any clinical operations begin, establish a compliant legal structure. If non-physician ownership or investment is involved, implement a Professional Corporation (PC)-Management Services Organization (MSO) model. Ensure the PC is owned by West Virginia-licensed professionals (e.g., physicians, dentists) and the MSO provides only non-clinical services under a fair market value Management Services Agreement (MSA). Avoid any arrangements that could be construed as fee-splitting or corporate control over clinical decisions. 2. Provider Licensure: All practitioners providing services to West Virginia patients must hold an active, unrestricted West Virginia license for their respective profession. For physicians, leverage the Interstate Medical Licensure Compact (IMLC) if eligible to expedite licensure. For nurses, the Nurse Licensure Compact (NLC) facilitates practice. Initiate licensure applications early, as processing times can vary, typically 3-6 months. 3. Telehealth Protocol Development: Develop comprehensive telehealth policies and procedures. These must address patient-provider relationship establishment (prioritizing synchronous audio-visual for initial encounters), informed consent, privacy (HIPAA compliance), data security, and emergency protocols. Ensure your telehealth platform is secure and compliant. 4. Prescribing Compliance: Implement strict protocols for prescribing, especially for controlled substances. Verify all prescribers have active DEA registration. Mandate and train on West Virginia's Prescription Drug Monitoring Program (CSMP) check requirements for controlled substances. For Schedule II controlled substances, plan for initial in-person exams or ensure compliance with any applicable federal or state waivers. 5. Scope of Practice Adherence: Clearly define the scope of practice for all clinical staff (physicians, NPs, PAs, RNs, MAs) based on West Virginia statutes and regulations. Ensure NPs have a compliant collaborative practice agreement and PAs have a supervision agreement. Strictly limit MAs to administrative or appropriately delegated non-invasive tasks. 6. Regulatory Monitoring: Designate a compliance officer or team to continuously monitor updates from the West Virginia Board of Medicine, Board of Osteopathic Medicine, Board of Pharmacy, and Board of Nursing. Regularly review legislative changes and proposed rules. Common Pitfalls to Avoid: Ignoring CPOM, inadequate provider licensure, improper establishment of patient-provider relationships via telehealth, non-compliance with controlled substance prescribing rules (especially PDMP checks), and allowing unlicensed personnel to perform medical acts. Timeline Expectations: Licensure can take several months. Business entity formation and MSA drafting typically take 1-3 months. Allow ample time for legal review and compliance audits before launching operations.